In 2024, new medicines changed how we think about healthy weight loss—but psychological factors remain just as important as ...

The Global Metabolism Drugs Market, valued at approximately USD 16.10 billion in 2022, is projected to grow at a robust CAGR of more than 6.50% during the forecast period from 2023 to 2030. Metabolism ...

Originally developed for Type 2 diabetes, these medications have proven highly effective for treating obesity—a chronic ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

Nearly half of US adults admit they’d take one of the newer, injectable weight loss drugs, but that number falls ...

But without much media fanfare, the U.S. has recently experienced a boomlet in good health news. In May 2024, the U.S.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 502.93% and ...

Among the many newcomers to the business of weight-loss drugs is Hims & Hers, an American e-pharmacy better known for hawking ...

Here, we discuss four biotech stocks, ADMA, TARS, STOK and CDXC, which have returned more than 50% year to date and have room for more growth in 2025.

The US Food and Drug Administration approved a new indication for Eli Lilly’s formulation of tirzepatide to treat moderate to ...